Peter Hoskin

Search results

• A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation

  Peter Hoskin (Participant), Angela R. McLean (Participant), Ella K Adlen (Participant), Elisabeth Cardis (Participant), Dudley T Goodhead (Participant), Mats Harms-Ringdahl (Participant), JH. Hendry (Participant), Penny A. Jeggo (Participant), DJC Mackay (Participant), Colin R Muirhead (Participant), J Shepherd (Participant), R. E. Shore (Participant), GA Thomas (Participant), R Wakeford (Participant) & H. Charles J Godfray (Participant)

  Impact: Health impacts

• Colorectal cancer: Summary of NICE guidance

  Peter Hoskin (Participant)

  Impact: Health impacts

• Contributed to European Cancer Organisation (ECCO) Essential Requirements for Quality Cancer Care: Prostate cancer guidelines 2020.

  Peter Hoskin (Participant)

  Impact: Health and wellbeing

• EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort(†): Under the Auspices of the EAU-ESMO Guidelines Committees

  Peter Hoskin (Participant)

  Impact: Health impacts

• ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer

  Peter Hoskin (Participant), Carl Salembier (Participant), Geert Villeirs (Participant), B De Bari (Participant), Bradley R Pieters (Participant), Marco van Vulpen (Participant), V Khoo (Participant), A Henry (Participant), Alberto Bossi (Participant), Gert De Meerleer (Participant) & Valérie Fonteyne (Participant)

  Impact: Health impacts

• GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update.

  Peter Hoskin (Participant), A. Colombo (Participant), A Henry (Participant), P Niehoff (Participant), Taran Paulsen Hellebust (Participant), Frank-Andre Siebert (Participant) & G Kovacs (Participant)

  Impact

• Guidelines for the first line management of classical Hodgkin lymphoma

  Peter Hoskin (Participant), George A. Follows (Participant), Kirit M. Ardeshna (Participant), S. F. Barrington (Participant), Dominic J Culligan (Participant), DC Linch (Participant), Shalal Sadullah (Participant), M V Williams (Participant) & Jennifer Z Wimperis (Participant)

  Impact

• Identifying molecular markers for improving the outcomes of radiotherapy and leading to spin out company Mantra Diagnostics

  Catharine West (Participant), Ananya Choudhury (Participant), Peter Hoskin (Participant) & Tim Smith (Participant)

  Impact: Health and wellbeing, Economic

• Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

  Peter Hoskin (Participant), M Fallon (Participant), R. Giusti (Participant), F Aielli (Participant), R Rolke (Participant), M Sharma (Participant) & C I Ripamonti (Participant)

  Impact

• NICE Prostate cancer: diagnosis and management clinical guideline [CG175]

  Peter Hoskin (Participant)

  Impact

• Non-Hodgkin’s lymphoma: diagnosis and management NICE guideline [NG52]

  Peter Hoskin (Participant)

  Impact: Health impacts

• Recommendations for Radiotherapy Technique and Dose in Extra-nodal Lymphoma

  Peter Hoskin (Participant), P Díez (Participant), E Gallop-Evans (Participant), Isabel Syndikus (Participant), A Bates (Participant) & M Bayne (Participant)

  Impact

• Recommendations for the Use of Radiotherapy in Nodal Lymphoma

  Peter Hoskin (Participant), P Díez (Participant), M Williams (Participant), H Lucraft (Participant) & M Bayne (Participant)

  Impact